MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1182/blood.2023021815

Медицинская библиотека · Blood · 2024

The remission status of AML patients after allo-HCT is associated with a distinct single-cell bone marrow T-cell signature.

Mathioudaki Anna, Wang Xizhe, Sedloev David, Huth Richard, Kamal Aryan, Hundemer Michael, Liu Yi, Vasileiou Spyridoula, Lulla Premal, Müller-Tidow Carsten, Dreger Peter, Luft Thomas, Sauer Tim, Schmitt Michael, Zaugg Judith B, Pabst Caroline

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Acute myeloid leukemia (AML) is a hematologic malignancy for which allogeneic hematopoietic cell transplantation (allo-HCT) often remains the only curative therapeutic approach. However, incapability of T cells to recognize and eliminate residual leukemia stem cells might lead to an insufficient graft-versus-leukemia (GVL) effect and relapse. Here, we performed single-cell RNA-sequencing (scRNA-seq) on bone marrow (BM) T lymphocytes and CD34+ cells of 6 patients with AML 100 days after allo-HCT to identify T-cell signatures associated with either imminent relapse (REL) or durable complete remission (CR). We observed a higher frequency of cytotoxic CD8+ effector and gamma delta (γδ) T cells in CR vs REL samples. Pseudotime and gene regulatory network analyses revealed that CR CD8+ T cells were more advanced in maturation and had a stronger cytotoxicity signature, whereas REL samples were characterized by inflammatory tumor necrosis factor/NF-κB signaling and an immunosuppressive milieu. We identified ADGRG1/GPR56 as a surface marker enriched in CR CD8+ T cells and confirmed in a CD33-directed chimeric antigen receptor T cell/AML coculture model that GPR56 becomes upregulated on T cells upon antigen encounter and elimination of AML cells. We show that GPR56 continuously increases at the protein level on CD8+ T cells after allo-HCT and confirm faster interferon gamma (IFN-γ) secretion upon re-exposure to matched, but not unmatched, recipient AML cells in the GPR56+ vs GPR56- CD8+ T-cell fraction. Together, our data provide a single-cell reference map of BM-derived T cells after allo-HCT and propose GPR56 expression dynamics as a surrogate for antigen encounter after allo-HCT.

Для цитирования: Mathioudaki Anna, Wang Xizhe, Sedloev David, Huth Richard, Kamal Aryan, Hundemer Michael, Liu Yi, Vasileiou Spyridoula, Lulla Premal, Müller-Tidow Carsten, Dreger Peter, Luft Thomas, Sauer Tim, Schmitt Michael, Zaugg Judith B, Pabst Caroline. The remission status of AML patients after allo-HCT is associated with a distinct single-cell bone marrow T-cell signature.. Blood. 2024. DOI: 10.1182/blood.2023021815.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.